USPTO trademark

WELZOQAR

Opposition periodUSPTOWord markClass 5

"WELZOQAR" is a word mark owned by Juno Therapeutics, Inc., filed at the USPTO on June 15, 2026. It is in its opposition period and covers class 5 (Pharmaceuticals).

View Juno Therapeutics, Inc. portfolioGet this data via the API
Official USPTO record
WELZOQAR trademark as filed
As filed with the USPTO
Status
Opposition period
Since October 20, 2026
Filed
June 15, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99885909
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns WELZOQAR

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Juno Therapeutics, Inc.

BMY · Seattle, United States

382 trademarks in the portfolioView company

Representative

Xiomara Triana

Bristol-Myers Squibb Company

Goods and services

What the mark covers

The products and services WELZOQAR is filed for, grouped by Nice class.

  • Antivirals; Antibodies for medical purposes; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes; Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, autoimmune diseases, solid organ transplant rejection, autoinflammatory diseases, blood diseases, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, Alzheimer’s disease, autism spectrum disorder, and musculoskeletal and skin diseases; Biological preparations for the treatment of cancer

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Official gazette publication confirmation e-mailed
  2. Published for opposition
  3. Notification of notice of publication e-mailed
  4. Approved for pub - principal register
  5. Assigned to examiner
  6. Application filing receipt mailed
  7. New application office supplied data entered
  8. New application entered
FAQ

About WELZOQAR

Who owns the trademark "WELZOQAR"?

The USPTO trademark "WELZOQAR" (application 99885909) is owned by Juno Therapeutics, Inc.

What is the status of "WELZOQAR"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull WELZOQAR and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019ed402-af3b-72bf-8fa8-025199e78021
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019ed402-af3b-72bf-8fa8-025199e78021",
  "object": "trademark",
  "mark_text": "WELZOQAR",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "99885909",
  "filing_date": "2026-06-15",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Juno Therapeutics, Inc.",
      "entity_id": "ent_019ebb07-7485-715a-bb4f-5244d59e8f19"
    }
  ]
}